메디칼아이덴터티코리아

비상장계속사업자

MEDICAL IDENTITY KOREA

전유홍

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

메디칼아이덴터티코리아

Business Reg. No. 2158703987 · CEO 전유홍

I.Investment Overview

Target메디칼아이덴터티코리아 (2158703987)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명메디칼아이덴터티코리아
영문명MEDICAL IDENTITY KOREA
대표자전유홍
사업자등록번호2158703987
법인등록번호1101113704742
설립일2007.06.25
종업원수28명

V.Workforce

28

Current headcount · 2026.06 as of

VI.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW2122021225.62022274.92023275.52024381.62025
영업이익100M KRW35.5202123.5202244.5202344.4202479.52025
순이익100M KRW28.7202119.6202236.5202333.7202467.92025
Item20252024202320222021
자산총계356.7억원267.7억원217.5억원177.1억원159억원
부채총계98.1억원76.8억원60억원55.9억원57.1억원
자본총계258.6억원191억원157.5억원121.2억원101.9억원
매출액381.6억원275.5억원274.9억원225.6억원212억원
영업이익79.5억원44.4억원44.5억원23.5억원35.5억원
순이익67.9억원33.7억원36.5억원19.6억원28.7억원

VII.Financial Ratios

FY2025 basis

20.84%

영업이익률

17.79%

순이익률

19.03%

ROA

26.25%

ROE

37.95%

부채비율

72.49%

자기자본비율

VIII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

메디칼아이덴터티코리아 투심보고서 | Alpha Lenz